Cargando…
Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?
The increasing efficacy of cancer therapeutics means that the timespan of cancer therapy administration is undergoing a transition to increasingly long-term settings. Unfortunately, chronic therapy-related adverse health events are an unintended, but not infrequent, outcome of these life-saving ther...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048033/ https://www.ncbi.nlm.nih.gov/pubmed/32154005 http://dx.doi.org/10.1186/s40959-018-0031-4 |